Your browser is no longer supported. Please, upgrade your browser.
ICCC ImmuCell Corporation daily Stock Chart
ICCC [NASD]
ImmuCell Corporation
Index- P/E- EPS (ttm)-0.22 Insider Own1.40% Shs Outstand7.21M Perf Week10.90%
Market Cap40.48M Forward P/E- EPS next Y-0.12 Insider Trans12.91% Shs Float5.14M Perf Month0.78%
Income-1.60M PEG- EPS next Q-0.10 Inst Own13.10% Short Float0.40% Perf Quarter28.74%
Sales14.20M P/S2.85 EPS this Y55.10% Inst Trans-7.33% Short Ratio0.63 Perf Half Y11.58%
Book/sh4.02 P/B1.37 EPS next Y47.80% ROA-4.00% Target Price- Perf Year-7.18%
Cash/sh0.95 P/C5.78 EPS next 5Y- ROE-5.40% 52W Range3.70 - 8.13 Perf YTD7.24%
Dividend- P/FCF- EPS past 5Y-28.00% ROI-2.60% 52W High-32.07% Beta1.26
Dividend %- Quick Ratio5.00 Sales past 5Y12.60% Gross Margin47.60% 52W Low49.27% ATR0.42
Employees54 Current Ratio5.90 Sales Q/Q11.40% Oper. Margin-7.30% RSI (14)49.01 Volatility7.47% 7.59%
OptionableNo Debt/Eq0.30 EPS Q/Q-156.50% Profit Margin-11.00% Rel Volume0.34 Prev Close5.61
ShortableYes LT Debt/Eq0.28 EarningsAug 12 AMC Payout- Avg Volume33.08K Price5.52
Recom2.00 SMA20-5.15% SMA507.40% SMA20012.67% Volume11,161 Change-1.55%
Aug-06-20 08:00AM  
Jul-07-20 08:00AM  
Jun-16-20 08:00AM  
May-18-20 11:48AM  
May-14-20 01:35PM  
08:42AM  
May-13-20 04:05PM  
May-07-20 12:00PM  
Apr-20-20 10:52AM  
Apr-14-20 08:00AM  
Apr-03-20 07:36AM  
Apr-02-20 04:29PM  
Mar-11-20 04:05PM  
Mar-01-20 09:09AM  
Feb-26-20 01:09AM  
Feb-19-20 12:35PM  
Feb-18-20 04:05PM  
Feb-13-20 09:17AM  
Jan-24-20 12:04PM  
08:35AM  
Jan-21-20 12:30PM  
Jan-06-20 02:25PM  
Dec-22-19 01:21PM  
Dec-19-19 11:38AM  
Nov-12-19 09:37AM  
Nov-11-19 04:05PM  
Nov-05-19 08:00AM  
Sep-17-19 08:00AM  
Sep-11-19 08:00AM  
Sep-06-19 11:43PM  
Aug-29-19 08:00AM  
Aug-12-19 04:05PM  
Aug-11-19 03:46PM  
Aug-06-19 08:00AM  
May-21-19 11:20AM  
May-14-19 07:42AM  
May-13-19 04:05PM  
May-07-19 09:00AM  
Mar-29-19 11:45AM  
Mar-27-19 07:30AM  
Mar-26-19 04:10PM  
Mar-22-19 10:48AM  
Mar-07-19 02:04PM  
Feb-28-19 02:00PM  
Feb-14-19 07:50AM  
Feb-13-19 04:05PM  
Feb-06-19 09:27AM  
Jan-11-19 02:00PM  
Dec-11-18 08:00AM  
Nov-23-18 08:00AM  
Nov-13-18 04:05PM  
Nov-08-18 08:00AM  
Nov-07-18 09:16AM  
Sep-26-18 03:25PM  
Sep-25-18 04:16PM  
Aug-30-18 11:02AM  
Aug-14-18 07:00AM  
Aug-13-18 04:05PM  
Aug-07-18 10:30AM  
06:30AM  
Jul-25-18 06:30AM  
Jul-10-18 06:30AM  
Jun-25-18 06:30AM  
Jun-07-18 02:02PM  
May-23-18 12:03PM  
May-22-18 07:20AM  
May-14-18 04:05PM  
12:30PM  
May-07-18 11:00AM  
Apr-11-18 02:07PM  
Mar-05-18 07:55PM  
Feb-12-18 07:16AM  
Feb-08-18 04:05PM  
12:00PM  
Feb-05-18 05:10PM  
Jan-30-18 06:30AM  
Dec-25-17 09:31AM  
Dec-21-17 11:00AM  
Dec-19-17 06:30AM  
Nov-22-17 02:48PM  
Nov-13-17 04:05PM  
11:30AM  
Nov-07-17 06:30AM  
Nov-02-17 11:14AM  
Oct-06-17 09:14AM  
Oct-05-17 09:16AM  
Sep-13-17 06:30AM  
Aug-17-17 10:16PM  
Aug-14-17 04:05PM  
01:00PM  
Aug-07-17 08:00AM  
Jul-27-17 04:05PM  
Jul-17-17 08:00AM  
Jul-13-17 04:05PM  
Jun-13-17 10:03AM  
May-19-17 04:56AM  
May-15-17 02:11PM  
May-12-17 09:05AM  
May-11-17 04:05PM  
May-04-17 08:00AM  
ImmuCell Corporation, an animal health company, acquires, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was founded in 1982 and is headquartered in Portland, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cunningham DavidDirectorMar 12Buy4.002,0008,00015,000Mar 12 04:35 PM
Tomsche David ScottDirectorMar 11Buy4.284,60019,68885,519Mar 12 11:03 AM
Tomsche David ScottDirectorFeb 27Buy4.985,13025,54780,919Mar 02 08:36 AM